Sun, March 15, 2009

Indigo Now Offers Latisse Eyelash Enhancement

Longer, thicker, darker lashes - now!

Indigo MedSpa is proud to announce that we now offer Latisse Eyelash Enhancer, a treatment to lengthen, darken and thicken the eyelashes. To learn more about Latisse's FDA approval, and what it can do for you, read the blog entry below which was taken from "SkinCare Blog"

http://www.skincareblog.net/2008/12/26/latisse-eyelash-treatment/

The U.S. Food and Drug Administration (FDA) has approved LATISSE (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.

"LATISSE fulfills a significant and previously unmet need in the medical aesthetic marketplace with a product approved by the FDA that increases the growth of eyelashes, making them longer, thicker and darker," said Scott Whitcup, M.D., Allergan's Executive Vice President of Research and Development. "As the global leader in medical aesthetics, LATISSE exemplifies our continuing commitment to developing innovative treatments that are studied in well-controlled clinical trials, manufactured to pharmaceutical standards, appropriately labeled for use, and available to consumers as a prescription product."

Available only through a doctor, LATISSE is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE is required. If use of LATISSE is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).

Email this • Print This • Subscribe to this feed • Share on Facebook • Twit This! • Save to del.icio.us • Digg This! • Technorati Links • Permalink

Back to Archives -->